• Keren Wang, Yuqin Ye, Guang Sun, and Zheli Xu.
• Department of Breast Surgery, China Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130033, China.
• Am. J. Surg. 2013 Jan 1; 205 (1): 35-8.

BackgroundAlthough most breast abscesses can be treated with the current first-line treatment of antibiotics by needle aspiration, the therapeutic duration is lengthy and recurrences often occur. Therefore, we aimed to investigate the clinical efficacy of the Mammotome biopsy system (Johnson & Johnson Corp., New Brunswick, NJ) in a cohort of patients with breast abscesses.MethodsForty lactating and 30 nonlactating breast abscess patients with unfavorable outcomes with antibiotic treatment and/or needle aspiration failure were recruited and treated with the Mammotome biopsy system.ResultsSkin inflammation of all patients disappeared within 6 days with no recurrence. The clinical outcomes in patients with an abscess size ≤ 3.5 cm was significantly better than those with an abscess size >3.5 cm (P = .025).ConclusionsThe Mammotome biopsy system, an effective treatment strategy that is minimally invasive and less damaging, in combination with appropriate antibiotic therapy can be used safely as the first-line approach to breast abscess management.Copyright © 2013 Elsevier Inc. All rights reserved.

23 keywords...

hide…